Radar Landscapes Age Tech and Longevity Industry Landscape of the United States
Age Tech and Longevity industry in the United States — illustrated cover for the Age Tech and Longevity Landscape of the United States
Radar · Industry landscape · the United States

Age Tech and Longevity Industry Landscape of the United States

1,115 Age Tech and Longevity companies in the United States, in one picture: who is hiring, who is raising money, who founded them, where they are based, which skills employers want and where the research is going. Updated September 2026.

1,115companies tracked
$7.5Bdisclosed funding
61hiring right now
220events · 24 months

Who leads Age Tech and Longevity in the United States

Shows 1,115 U.S. Age Tech and Longevity firms, highlighting which are hiring, best funded, and currently hiring, with 61 firms hiring now and 260 having disclosed funding rounds.

open roles
Hiring now
ranked by live open roles
  1. 01Medical Guardian12last posted Jul 2026
  2. 02A Place for Mom11last posted Jun 2026
  3. 03SafelyYou10last posted Jun 2026
  4. 04Utah Retirement Systems10last posted Jun 2026
  5. 05Care.com10last posted Jun 2026
  6. 06AARP9last posted Apr 2026
  7. 07The Helper Bees8last posted Apr 2026
  8. 08IRA Financial7last posted Jun 2026
61 companies hiring · 0 posted in the last 30 days
disclosed funding
Most funded
disclosed totals, all rounds
  1. 01Human Interest$814MSeries E · Nov 2025
  2. 02NU Skin$750.8MUnattributed · Oct 2021
  3. 03Honor$510MConventional Debt · Oct 2021
  4. 04Guideline$344MSeries E · Jun 2021
  5. 05Papa$256.8MSeries D · Oct 2021
  6. 06Smart$225.4MSeries D · Jan 2022
  7. 07Vesta Healthcare$198MVenture Debt · Sep 2024
  8. 08A Place for Mom$184.5MSeries B · Jan 2022
260 companies with disclosed rounds · $7.5B total
revenue
Revenue leaders
official filings first, else latest snapshot
  1. 01NU Skin$320.6MFY2024 filing
  2. 02LifeVantage$43.7MFY2024 filing
  3. 03Ekso Bionics$2.1MFY2025 filing
  4. 04ZEO ScientifiX$95kFY2020 filing
4 companies with a revenue figure
headcount
Largest teams
ranked by tracked headcount
  1. 01AARP2,362tracked employees
  2. 02Honor1,902tracked employees
  3. 03NU Skin1,900tracked employees
  4. 04Papa853tracked employees
  5. 05Careforth580tracked employees
  6. 06Human Interest577tracked employees
  7. 07PCS Retirement341tracked employees
  8. 08Life Alert304tracked employees
56 companies with headcount data
share of events
Share of voice
share of all tracked sector news events, 24 months
  1. 01Ekso Bionics12.5%49 tracked events
  2. 02Telomir Pharmaceuticals12.5%49 tracked events
  3. 03NU Skin12.0%47 tracked events
  4. 04LifeVantage8.7%34 tracked events
  5. 05Honor8.4%33 tracked events
  6. 06LogicMark4.8%19 tracked events
  7. 07Vesta Healthcare3.1%12 tracked events
  8. 08Guideline2.8%11 tracked events
393 tracked events across 48 companies
web reach
Most-used apps
the sites in this sector the web visits most
  1. 01Find a Gravetop 5kfindagrave.com
  2. 02AARPtop 10kaarp.org
  3. 03Care.comtop 50kcare.com
  4. 04NU Skintop 50knuskin.com
  5. 05OurTime Datingtop 50kourtime.com
  6. 06One Skin Technologiestop 500koneskin.co
  7. 07Trust and Willtop 500ktrustandwill.com
  8. 08Stitchtop 500kstitch.net
353 companies here run a site with a measured audience · 57 of them sit inside the web’s top million
Radar

See all 1,115 Age Tech and Longevity companies in the United States

Filter by funding, headcount, hiring and location, and export the list.

How the Age Tech and Longevity ecosystem in the United States grew, 2016–2025

Displays the number of companies founded each year, peaking at 97 in 2020 and falling to 11 in 2025.

Companies founded / year
new Age Tech and Longevity companies in the United States
2016: 572017: 752018: 822019: 882020: 972021: 652022: 532023: 382024: 242025: 11
20162025
peak 97 in 2020
Companies raising / year
with a disclosed round that year
20162025
peak 55 in 2020
Disclosed funding / year
sum of disclosed rounds (USD)
2016: 158,962,9262017: 136,580,7112018: 1,010,953,9262019: 327,099,9972020: 585,206,6212021: 1,534,315,9122022: 957,437,0152023: 453,791,7952024: 651,638,4022025: 826,216,988
20162025
peak $1.5B in 2021

Where Age Tech and Longevity companies in the United States are based

New York City skyline — Age Tech and Longevity hub in the United States
Hub 01
New York City
74 Age Tech and Longevity companies
29% of the Age Tech and Longevity companies across these hubs
74companies
$733.2Mdisclosed funding
4hiring now
Photo Wikipedia · New York City · CC BY-SA 4.0
San Francisco skyline — Age Tech and Longevity hub in the United States
Hub 02
San Francisco
65 Age Tech and Longevity companies
25% of the Age Tech and Longevity companies across these hubs
65companies
$1.2Bdisclosed funding
7hiring now
Photo Wikipedia · San Francisco · CC BY-SA 4.0
Los Angeles skyline — Age Tech and Longevity hub in the United States
Hub 03
Los Angeles
26 Age Tech and Longevity companies
10% of the Age Tech and Longevity companies across these hubs
26companies
$112Mdisclosed funding
2hiring now
Photo Wikipedia · Los Angeles · CC BY-SA 4.0
Seattle skyline — Age Tech and Longevity hub in the United States
Hub 04
Seattle
23 Age Tech and Longevity companies
9% of the Age Tech and Longevity companies across these hubs
23companies
$240.1Mdisclosed funding
3hiring now
Photo Wikipedia · Seattle · CC BY-SA 4.0
Austin, a Age Tech and Longevity hub in the United States
Hub 05
Austin
20 Age Tech and Longevity companies
8% of the Age Tech and Longevity companies across these hubs
20companies
$154Mdisclosed funding
1hiring now
generated artwork
Chicago skyline — Age Tech and Longevity hub in the United States
Hub 06
Chicago
16 Age Tech and Longevity companies
6% of the Age Tech and Longevity companies across these hubs
16companies
$19Mdisclosed funding
Photo Wikipedia · Chicago · CC BY-SA 4.0
Houston skyline — Age Tech and Longevity hub in the United States
Hub 07
Houston
16 Age Tech and Longevity companies
6% of the Age Tech and Longevity companies across these hubs
16companies
$7.8Mdisclosed funding
Photo Wikipedia · Houston · CC BY-SA 4.0
Boston skyline — Age Tech and Longevity hub in the United States
Hub 08
Boston
15 Age Tech and Longevity companies
6% of the Age Tech and Longevity companies across these hubs
15companies
$67Mdisclosed funding
2hiring now
Photo Wikipedia · Boston · CC BY-SA 4.0

The Age Tech and Longevity market map of the United States: what these companies actually do

  • Consumer Digital802 companies · $3.3B raised · 39 hiring
  • Healthtech517 companies · $3.5B raised · 36 hiring
  • Enterprise Tech448 companies · $4.8B raised · 29 hiring
  • B2C E-Commerce242 companies · $2.1B raised · 22 hiring
  • IoT in Healthcare202 companies · $1.1B raised · 10 hiring
  • Medical Devices198 companies · $1.1B raised · 10 hiring
  • Fintech183 companies · $2.1B raised · 11 hiring
  • Enterprise Software178 companies · $1.9B raised · 14 hiring
  • Loneliness Economy176 companies · $1.8B raised · 13 hiring
  • Consumer Internet of Things171 companies · $397.2M raised · 7 hiring
  • Chronic Disease Management166 companies · $1.3B raised · 11 hiring
  • SaaS162 companies · $1.3B raised · 8 hiring

Monetization

How Age Tech and Longevity companies make money

How many companies earn revenue each way. Plenty use more than one model, so the counts add up to more than the sector.

Subscription738
Commission on Transaction310
Fee-For-Service192
E-Commerce - Product156
Advertising148
E-Commerce - Service124
Physical Commerce104
Sponsorship13

Funding, M&A and the deals moving Age Tech and Longevity in the United States

Funding 52Earnings 48Leadership 47M&A 24Product 17Announcement 15Contracts 6Capital 4Funds Raising 3Incorporation 1
  • M&AManhattan Beach-headquartered private equity firm Pacific Avenue Capital Partners announced that an affiliate has entered into an agreement to acquire Care.com, a digital marketplace for caregiving services, from IAC Inc.2026-04-01
  • FundingThe round was led by Lifeline Ventures, known for backing companies such as Oura, Supercell, and Wolt in their early stages. Additional investors include Tiny VC, Wave Ventures, and First Fellow Partners, alongside several angel investors, including Cal Henderson, the co-founder of Slack.2026-03-10
  • FundingChptr, a storytelling platform helping funeral homes share memorial stories with the communities they serve, has raised $3.25M in funding according to a recent SEC filing.2026-03-09
  • M&AApplied Digital plans to combine its cloud computing unit, Applied Digital Cloud, with EKSO.2025-12-30
  • M&ALifeVantage and LoveBiome: LifeVantage acquired LoveBiome to expand its gut health portfolio.2025-12-16
  • M&ACareScout has announced the acquisition of Seniorly (https://www.seniorly.com/).2025-11-14
  • FundingCarepool Innovation Inc., whose medical rideshare platform automates medical transportation, has landed significant new funding from Decathlon Capital Partners. The multi-million-dollar investment package will support the expansion of Carepool into new geographic markets.2025-10-27
  • M&ATelomir Pharmaceuticals, Inc. (NASDAQ:TELO) ('Telomir' or the 'Company'), a preclinical-stage biotechnology company developing therapies that target epigenetic drivers of cancer, aging, and age-related disease, today announced that it has executed a binding Letter of Intent (the 'LOI') to acquire TELI Pharmaceuticals, Inc.2025-10-21
  • FundingDUOS, a leading AI-powered digital health platform for member activation and benefits execution, today announced a $130 million strategic growth equity investment led by FTV Capital, a sector-focused growth equity firm with deep expertise in healthcare technology and services. The investment round also includes participation from Forerunner Ventures, DUOS’ earliest institutional investor, bringing the company full circle as it enters the next phase of growth.2025-10-14
  • M&ALast month, Gusto, a payroll and HR software company, announced that it agreed to acquire Guideline, a startup offering retirement plans to small and medium businesses.2025-10-01

Mergers and acquisitions

Deals from the last 24 months where a Age Tech and Longevity company in the United States was the buyer or the one bought, newest first. “Undisclosed” means the price was never published — not that the deal was worth nothing.

AcquirerTargetDeal valueStatusDate
baker tillyVanillaundisclosedAnnounced2026-05-01
pacific avenue capital partnersCare.comundisclosedAnnounced2026-04-01
IAC Inc.Care.com$500MCompleted2026-04-01
affiliate of Pacific Avenue Capital PartnersCare.com$320MAnnounced2026-03-02
applied digitalEkso BionicsundisclosedAnnounced2025-12-30
LifeVantageLoveBiomeundisclosedCompleted2025-12-16

Who is listing, hiring leaders, launching and winning work

Provides details on IPO filings, leadership changes, product launches and contract wins for companies in the sector.

IPO pipeline
3 companies listed or filing · last 24 months
Leadership moves
13 tracked people moves · last 12 months
  • LifeVantageTerrence Moorehead · Appointment → President and Chief Executive OfficerApr 2026
  • LifeVantageMichael Beindorff · Appointment → Interim Chief Executive OfficerApr 2026
  • LifeVantageSteve Fife · Retirement — was Chief Executive OfficerApr 2026
  • NU SkinChayce Clark · Appointment → Chief Operating OfficerApr 2026
  • A Place for MomChris Milone · Appointment → Chief Marketing OfficerApr 2026
  • NU SkinJames Thomas · Resignation — was Chief Financial OfficerMar 2026
  • NU SkinChelsea Lantz · Appointment → interim Chief Financial OfficerMar 2026
  • SavvlyRob Evans · Appointment → General CounselFeb 2026
Product launches
tracked launches · last 12 months
  • GuidelineData Insights Service (Analytics Service)Apr 2026
  • GuidelineKPI Forecast 2.0 (Analytics Solution)Apr 2026
  • NU SkinPrysm iO (Handheld wellness device)Apr 2026
  • HonorHONOR Magic V6 (AI‑native foldable smartphone)Mar 2026
  • HonorHONOR AI Connect Platform (AI device ecosystem platform)Mar 2026
  • Smart#2 (Electric car)Sep 2025
Contract wins
4 customer wins · last 24 months
Earnings pulse
companies reporting results · last 24 months
5 companies reporting50 company-quarters trackedbeat 8miss 5in line 2

Half of these companies grew revenue faster than -3.0%, half slower.

Who is building Age Tech and Longevity in the United States

Profiles 754 founders and CEOs across 563 firms, noting top alma maters like Harvard (17) and Stanford (14) and previous employers such as Microsoft (7).

Founders and chief executives12 of 754, from the best-funded companies on this page
Roger Lee
Co-Founder
Roger Lee
repeat founder

Co-Founder Comprehensive, ex-Co-Founder Thunder, SubProfile. Harvard University BA 2008

Seth Sternberg
Co-Founder & CEO
Seth Sternberg

Ex -Co-Founder & CEO Meebo, Google. Yale University BA 2001, Stanford University Graduate School of Business MBA 2005

Kevin Busque
Co-Founder & CEO
Kevin Busque

Ex-Co-Founder TaskRabbit, Humedica, Institute for Health Metrics, Founder LinkedUp. Fitchburg State University 2003…

Jake Rothstein
Co-Founder
Jake Rothstein

Upside, ex-Motionpoint, ex-Zudy Software, University of Florida

Duane Bernt
CEO
Duane Bernt

Ex - President Stadion Money Management, Senior Vice President Lincoln Financial Group. University of Nebraska-Lincoln BS…

Randall Klein
CEO
Randall Klein

Ypo Ny Liberty, ex-Remedy Partners, ex-Complex Care Solutions, New York University - Stern School of Business, 2005

Tatyana Zlotsky
Chief Executive Officer
Tatyana Zlotsky

A Place For Mom, ex-American Express, ex-Comcast, Harvard Business School, 2016

Jeffrey Cleland
Co-Founder & CEO
Jeffrey Cleland

Ex-Orpheris, Graybug Vision, Founder Versartis, PDMDC, Diartis Pharmaceuticals, BaroFold. University of California, Davis BS 1986, MIT PhD 1991

Karl Ulfers
Co-Founder & Chief Executive Officer
Karl Ulfers

Duos, ex-Stealth Venture, ex-Rally Health, Saint John's University, 1970

Ron Gura
Co-Founder & CEO
Ron Gura
repeat founder

Ex-WeWork, Aleph VC, eBay, Co-Founder The Gifts Project. Reichman University BA 2010, The Open University of Israel 2001

Sheila Marcelo
Founder
Sheila Marcelo
repeat founder

Founder Care, Ohai, ex-TheLadders, Upromise, Putnam Hayes & Bartlett. Mount Holyoke College BA 1993, HBS MBA 1998, Harvard Law School JD 1999

David Weisz
Co-Founder, CPO
David Weisz

Jibe Ventures, ex-Wix, ex-Israeli Navy, The Interdisciplinary Center, 2012

Where the founders studied
alma mater on record for 101 of 754 founders
Harvard University17
Stanford University14
Harvard Business School12
Massachusetts Institute of Technology7
Columbia University7
Cornell University6
University of California (Berkeley)5
University of Pennsylvania4
Where they worked before
a previous employer on record for 28 of 754 founders
Microsoft7
Intel5
Google3
Uber3
McKinsey2
Facebook2
Apple2
eBay1
Founders flagged as repeat founders
of 591 founders with a profile on this page
7
carry a repeat-founder flag
  • flagged as repeat founders7
  • no repeat-founder flag584
Women and men among the founders
first names matched for 696 of 754 founders
23%
of matched founders are women
  • women157
  • men539
Inferred from first names, using 119 million people who state their own gender: a first name counts only where at least 20 of them share it and at least 90% of those share the same gender. The other 58 founders go in neither column.
Radar

Look up the people behind Age Tech and Longevity companies in the United States

Search founders, executives and operators by company, role and location.

Who funds Age Tech and Longevity in the United States

Records 609 funding rounds since 2016 from 708 investors, with an average round size of $2.3 million.

Investor · most active investors since 2016RoundsLedLatest
HHS64Sep 2025
Techstars179Nov 2023
Y Combinator125Sep 2025
General Catalyst93Aug 2025
Revolution91Apr 2024
SV Health Investors73Jun 2023
Primetime Partners71Sep 2023
Foundation Capital71Jan 2025
Alumni Ventures71Apr 2026
Andreessen Horowitz63Sep 2023
Stage mix · rounds since 2016
Seed & Angel233
Series A–B174
Series C+ / PE47
Grants, debt & other155

The typical round is $2.3M — half were bigger, half smaller.

The biggest Age Tech and Longevity funding rounds in the United States

Highlights the largest disclosed round—Human Interest’s $242 million Series E—and lists ten other large recent rounds.

CompanyRoundSizeWhenBackers
Human InterestSeries E$242MMar 2024Baillie Gifford, Marshall Wace, Morgan Stanley
SmartSeries D$225.4MJan 2022
GuidelineSeries E$200MJun 2021General Atlantic, Generation Investment Management, Greyhound Capital +2 more
Human InterestSeries D$200MAug 2021The Rise Fund, NewView Capital, Wing Venture Capital +8 more
A Place for MomSeries B$175MJan 2022Insight Partners, General Atlantic, Silver Lake
PapaSeries D$150MOct 2021TCG Ventures, SoftBank Vision Fund, Canaan +3 more
HonorSeries D$140MOct 2020Baillie Gifford, Prosus, Andreessen Horowitz +3 more
DUOSSeries B$130MOct 2025FTV Capital, Forerunner Ventures
Human InterestSeries E$100MNov 2025Morgan Stanley, BlackRock, Baillie Gifford +1 more
Character BiosciencesSeries B$93MMar 2025aMoon, Luma Group, Bausch & Lomb +6 more
Venture round sizes · 2023–2025
<$1M25
$1–10M44
$10–50M32
$50–250M10
>$250M0

111 venture rounds with a disclosed amount in the window.

Fresh cheques · last 6 months

Age Tech and Longevity jobs in the United States: who is hiring and what they ask for

Summarizes 1,049 job postings in the last year from 117 employers, with median pay of $52 k and top‑required skills including lifting, CNA license, Excel, React and CRM.

1,049postings · last 12 months
2,181postings tracked overall
117employers advertising
$52kmedian advertised salary/yr (n=199)

Demand

The Skills Employers Ask For

What Age Tech and Longevity employers in the United States put in their job ads. The bar is how many postings ask for it; the arrow shows whether demand grew or shrank against the year before.

  • lifting52
  • cna license50
  • excel21
  • react17
  • crm15
  • aws15
  • memory impairment12
  • word11
  • lpn10
  • sql10
What level are these roles?
Entry33
Intern46
Senior139
Lead23
Manager348
Most advertised titles
  • Manager44
  • Dog Sitter30
  • Pet Sitter30
  • Graduate Consultant27
  • Healthcare Account Executive27
  • Caregiver / Home Care Aide26

What Age Tech and Longevity research in the United States is working on

Counts 11,793 U.S. academic papers, of which 1,319 identify common problems, 670 issue cautions, and 7,239 discuss opportunities.

How this field talks about itself
United States-affiliated Age Tech and Longevity papers (gold) against all published research (grey)
Promising37.9% · 36.9%≈ par
Breakthrough23.5% · 26.5%≈ par
Descriptive20.1% · 17.6%≈ par
Problem-identifying7.7% · 9.7%0.8×
Cautionary5.7% · 4.6%1.2×
Critical3.5% · 0.9%3.9×
How the work is done
Empirical74.1%
Reviews13.6%
Methods-led7.6%
Position pieces3.1%
Theoretical1.6%
How the research reads

88% positive · 6% neutral · 6% negative, across 11,793 papers.

The institutions doing the work · United States
  • Buck Institute for Research on Aging36k
  • Harvard University31k
  • Lawrence Berkeley National Laboratory23k
  • Mayo Clinic in Florida23k
  • Mayo Clinic18k
  • National Institute on Aging16k

ranked by how often their work is cited

Leading researchers · United States-affiliated work

Judith Campisi · Jean‐Philippe Coppé · Tamar Tchkonia · Pierre‐Yves Desprez · James L. Kirkland · Ana Krtolica · Marco Demaria · Yi Zhu

The most-cited breakthroughs
  • Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor · 4k cites
  • Cellular senescence mediates fibrotic pulmonary disease · 2k cites
  • A proteomic atlas of senescence-associated secretomes for aging biomarker development · 1k cites
  • Fat tissue, aging, and cellular senescence · 1k cites
  • Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity · 968 cites
Common problems researchers identify1,221 papers · 7 recurring themes
Immune System / Disease — Common problems researchers identify
Problems · theme 01
Immune System / Disease
219 papers · 17.9% of this block
2022: 3,331 of every 10,000 papers on this subject2023: 3,352 of every 10,000 papers on this subject2024: 3,155 of every 10,000 papers on this subject2025: 3,356 of every 10,000 papers on this subject2022: 3,331 of every 10,000 papers on this subject2023: 3,352 of every 10,000 papers on this subject2024: 3,155 of every 10,000 papers on this subject2025: 3,356 of every 10,000 papers on this subject→ +1% share2022→2025 share of research on this subject
Immune system · Disease · Immunosenescence · Neuroscience
“On the Immunological Theory of Aging”
219 of these papers raise it as a problem
Senescence / Cellular Senescence — Common problems researchers identify
Problems · theme 02
Senescence / Cellular Senescence
216 papers · 17.7% of this block
2022: 1,887 of every 10,000 papers on this subject2023: 2,121 of every 10,000 papers on this subject2024: 1,779 of every 10,000 papers on this subject2025: 1,141 of every 10,000 papers on this subject2022: 1,887 of every 10,000 papers on this subject2023: 2,121 of every 10,000 papers on this subject2024: 1,779 of every 10,000 papers on this subject2025: 1,141 of every 10,000 papers on this subject▼ -40% share2022→2025 share of research on this subject
Senescence · Cellular senescence · Cell biology · Phenotype
“Assessing Cell and Organ Senescence Biomarkers”
216 of these papers raise it as a problem
Gerontology / Longevity — Common problems researchers identify
Problems · theme 03
Gerontology / Longevity
186 papers · 15.2% of this block
2022: 1,861 of every 10,000 papers on this subject2023: 1,835 of every 10,000 papers on this subject2024: 2,190 of every 10,000 papers on this subject2025: 1,419 of every 10,000 papers on this subject2022: 1,861 of every 10,000 papers on this subject2023: 1,835 of every 10,000 papers on this subject2024: 2,190 of every 10,000 papers on this subject2025: 1,419 of every 10,000 papers on this subject▼ -24% share2022→2025 share of research on this subject
Gerontology · Longevity · Healthy aging · Psychological intervention
“The Biology of Aging”
186 of these papers raise it as a problem
Longevity / Longevity Risk — Common problems researchers identify
Problems · theme 04
Longevity / Longevity Risk
162 papers · 13.3% of this block
2022: 308 of every 10,000 papers on this subject2023: 287 of every 10,000 papers on this subject2024: 329 of every 10,000 papers on this subject2025: 216 of every 10,000 papers on this subject2022: 308 of every 10,000 papers on this subject2023: 287 of every 10,000 papers on this subject2024: 329 of every 10,000 papers on this subject2025: 216 of every 10,000 papers on this subject▼ -30% share2022→2025 share of research on this subject
Longevity · Longevity risk · Ecology · Evolutionary biology
“The evolutionary ecology of senescence”
162 of these papers raise it as a problem
Reproduction / Fecundity — Common problems researchers identify
Problems · theme 05
Reproduction / Fecundity
153 papers · 12.5% of this block
2022: 248 of every 10,000 papers on this subject2023: 225 of every 10,000 papers on this subject2024: 235 of every 10,000 papers on this subject2025: 239 of every 10,000 papers on this subject2022: 248 of every 10,000 papers on this subject2023: 225 of every 10,000 papers on this subject2024: 235 of every 10,000 papers on this subject2025: 239 of every 10,000 papers on this subject▼ -4% share2022→2025 share of research on this subject
Reproduction · Fecundity · Longevity · Life history theory
“Life histories and the evolution of cooperative breeding in mammals”
153 of these papers raise it as a problem
Demography / Life Expectancy — Common problems researchers identify
Problems · theme 06
Demography / Life Expectancy
145 papers · 11.9% of this block
2022: 2,006 of every 10,000 papers on this subject2023: 1,969 of every 10,000 papers on this subject2024: 2,304 of every 10,000 papers on this subject2025: 1,509 of every 10,000 papers on this subject2022: 2,006 of every 10,000 papers on this subject2023: 1,969 of every 10,000 papers on this subject2024: 2,304 of every 10,000 papers on this subject2025: 1,509 of every 10,000 papers on this subject▼ -25% share2022→2025 share of research on this subject
Demography · Life expectancy · Longevity · Gerontology
“Measuring Recent Apparent Declines In Longevity: The Role Of Increasing Educational Attainment”
145 of these papers raise it as a problem
Longevity / Internal Medicine — Common problems researchers identify
Problems · theme 07
Longevity / Internal Medicine
140 papers · 11.5% of this block
2022: 3,042 of every 10,000 papers on this subject2023: 3,310 of every 10,000 papers on this subject2024: 3,010 of every 10,000 papers on this subject2025: 1,892 of every 10,000 papers on this subject2022: 3,042 of every 10,000 papers on this subject2023: 3,310 of every 10,000 papers on this subject2024: 3,010 of every 10,000 papers on this subject2025: 1,892 of every 10,000 papers on this subject▼ -38% share2022→2025 share of research on this subject
Longevity · Internal medicine · Caloric theory · Insulin
“Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in <i>C. elegans</i>”
140 of these papers raise it as a problem
Cautions638 papers · 7 recurring themes
Longevity / Fecundity — Cautions
Cautions · theme 01
Longevity / Fecundity
168 papers · 26.3% of this block
2022: 961 of every 10,000 papers on this subject2023: 945 of every 10,000 papers on this subject2024: 719 of every 10,000 papers on this subject2025: 546 of every 10,000 papers on this subject2022: 961 of every 10,000 papers on this subject2023: 945 of every 10,000 papers on this subject2024: 719 of every 10,000 papers on this subject2025: 546 of every 10,000 papers on this subject▼ -43% share2022→2025 share of research on this subject
Longevity · Fecundity · Population · Juvenile
“Cattle adapted to tropical and subtropical environments: genetic and reproductive considerations”
168 of these papers raise it as a problem
Senescence / Cell Biology — Cautions
Cautions · theme 02
Senescence / Cell Biology
106 papers · 16.6% of this block
2022: 2,108 of every 10,000 papers on this subject2023: 2,335 of every 10,000 papers on this subject2024: 2,020 of every 10,000 papers on this subject2025: 1,456 of every 10,000 papers on this subject2022: 2,108 of every 10,000 papers on this subject2023: 2,335 of every 10,000 papers on this subject2024: 2,020 of every 10,000 papers on this subject2025: 1,456 of every 10,000 papers on this subject▼ -31% share2022→2025 share of research on this subject
Senescence · Cell biology · Stem cell · Progenitor cell
“Ageing compromises mouse thymus function and remodels epithelial cell differentiation”
106 of these papers raise it as a problem
Longevity / Gerontology — Cautions
Cautions · theme 03
Longevity / Gerontology
102 papers · 16.0% of this block
2022: 2,006 of every 10,000 papers on this subject2023: 1,969 of every 10,000 papers on this subject2024: 2,304 of every 10,000 papers on this subject2025: 1,509 of every 10,000 papers on this subject2022: 2,006 of every 10,000 papers on this subject2023: 1,969 of every 10,000 papers on this subject2024: 2,304 of every 10,000 papers on this subject2025: 1,509 of every 10,000 papers on this subject▼ -25% share2022→2025 share of research on this subject
Longevity · Gerontology · Life expectancy · Demography
“Animal Models of Aging Research: Implications for Human Aging and Age-Related Diseases”
102 of these papers raise it as a problem
Senescence / Mesenchymal Stem Cell — Cautions
Cautions · theme 04
Senescence / Mesenchymal Stem Cell
84 papers · 13.2% of this block
2022: 1,669 of every 10,000 papers on this subject2023: 2,433 of every 10,000 papers on this subject2024: 1,563 of every 10,000 papers on this subject2025: 1,051 of every 10,000 papers on this subject2022: 1,669 of every 10,000 papers on this subject2023: 2,433 of every 10,000 papers on this subject2024: 1,563 of every 10,000 papers on this subject2025: 1,051 of every 10,000 papers on this subject▼ -37% share2022→2025 share of research on this subject
Senescence · Mesenchymal stem cell · Cancer research · Cell biology
“Human Obesity Induces Dysfunction and Early Senescence in Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells”
84 of these papers raise it as a problem
Longevity / Caenorhabditis Elegans — Cautions
Cautions · theme 05
Longevity / Caenorhabditis Elegans
72 papers · 11.3% of this block
2022: 2,173 of every 10,000 papers on this subject2023: 2,452 of every 10,000 papers on this subject2024: 2,115 of every 10,000 papers on this subject2025: 1,370 of every 10,000 papers on this subject2022: 2,173 of every 10,000 papers on this subject2023: 2,452 of every 10,000 papers on this subject2024: 2,115 of every 10,000 papers on this subject2025: 1,370 of every 10,000 papers on this subject▼ -37% share2022→2025 share of research on this subject
Longevity · Caenorhabditis elegans · Drosophila melanogaster · Genetics
“Uncoupling lifespan and healthspan in <i>Caenorhabditis elegans</i> longevity mutants”
72 of these papers raise it as a problem
Internal Medicine / Calorie Restriction — Cautions
Cautions · theme 06
Internal Medicine / Calorie Restriction
72 papers · 11.3% of this block
2022: 3,268 of every 10,000 papers on this subject2023: 3,524 of every 10,000 papers on this subject2024: 3,220 of every 10,000 papers on this subject2025: 2,011 of every 10,000 papers on this subject2022: 3,268 of every 10,000 papers on this subject2023: 3,524 of every 10,000 papers on this subject2024: 3,220 of every 10,000 papers on this subject2025: 2,011 of every 10,000 papers on this subject▼ -38% share2022→2025 share of research on this subject
Internal medicine · Calorie restriction · Endocrinology · Caloric theory
“Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment”
72 of these papers raise it as a problem
Honey Bee / Pesticide — Cautions
Cautions · theme 07
Honey Bee / Pesticide
34 papers · 5.3% of this block
2022: 13 of every 10,000 papers on this subject2023: 13 of every 10,000 papers on this subject2024: 13 of every 10,000 papers on this subject2025: 12 of every 10,000 papers on this subject2022: 13 of every 10,000 papers on this subject2023: 13 of every 10,000 papers on this subject2024: 13 of every 10,000 papers on this subject2025: 12 of every 10,000 papers on this subject▼ -7% share2022→2025 share of research on this subject
Honey bee · Pesticide · Imidacloprid · Brood
“Factors affecting the reproductive health of honey bee (Apis mellifera) drones—a review”
34 of these papers raise it as a problem
Opportunities6,823 papers · 7 recurring themes
Senescence / Autophagy — Opportunities
Opportunities · theme 01
Senescence / Autophagy
1,130 papers · 18.8% of this block
2022: 3,279 of every 10,000 papers on this subject2023: 3,550 of every 10,000 papers on this subject2024: 3,262 of every 10,000 papers on this subject2025: 2,186 of every 10,000 papers on this subject2022: 3,279 of every 10,000 papers on this subject2023: 3,550 of every 10,000 papers on this subject2024: 3,262 of every 10,000 papers on this subject2025: 2,186 of every 10,000 papers on this subject▼ -33% share2022→2025 share of research on this subject
Senescence · Autophagy · Internal medicine · Oxidative stress
“Age-dependent effects of <i>Igf2bp2</i> on gene regulation, function, and aging of hematopoietic stem cells in mice”
Senescence / Cell Biology — Opportunities
Opportunities · theme 02
Senescence / Cell Biology
1,109 papers · 18.5% of this block
2022: 1,887 of every 10,000 papers on this subject2023: 2,121 of every 10,000 papers on this subject2024: 1,779 of every 10,000 papers on this subject2025: 1,141 of every 10,000 papers on this subject2022: 1,887 of every 10,000 papers on this subject2023: 2,121 of every 10,000 papers on this subject2024: 1,779 of every 10,000 papers on this subject2025: 1,141 of every 10,000 papers on this subject▼ -40% share2022→2025 share of research on this subject
Senescence · Cell biology · Cellular senescence · Phenotype
“Cellular Senescence and the Biology of Aging, Disease, and Frailty”
Senescence / Cell Biology — Opportunities
Opportunities · theme 03
Senescence / Cell Biology
944 papers · 15.7% of this block
2022: 1,939 of every 10,000 papers on this subject2023: 2,169 of every 10,000 papers on this subject2024: 1,827 of every 10,000 papers on this subject2025: 1,231 of every 10,000 papers on this subject2022: 1,939 of every 10,000 papers on this subject2023: 2,169 of every 10,000 papers on this subject2024: 1,827 of every 10,000 papers on this subject2025: 1,231 of every 10,000 papers on this subject▼ -36% share2022→2025 share of research on this subject
Senescence · Cell biology · Mesenchymal stem cell · Inflammation
“Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity”
Longevity / Gerontology — Opportunities
Opportunities · theme 04
Longevity / Gerontology
906 papers · 15.1% of this block
2022: 2,006 of every 10,000 papers on this subject2023: 1,969 of every 10,000 papers on this subject2024: 2,304 of every 10,000 papers on this subject2025: 1,509 of every 10,000 papers on this subject2022: 2,006 of every 10,000 papers on this subject2023: 1,969 of every 10,000 papers on this subject2024: 2,304 of every 10,000 papers on this subject2025: 1,509 of every 10,000 papers on this subject▼ -25% share2022→2025 share of research on this subject
Longevity · Gerontology · Demography · Life expectancy
“The Search for Longevity and Healthy Aging Genes: Insights From Epidemiological Studies and Samples of Long-Lived Individuals”
Cancer Research / Cancer — Opportunities
Opportunities · theme 05
Cancer Research / Cancer
726 papers · 12.1% of this block
2022: 2,019 of every 10,000 papers on this subject2023: 2,800 of every 10,000 papers on this subject2024: 1,955 of every 10,000 papers on this subject2025: 1,640 of every 10,000 papers on this subject2022: 2,019 of every 10,000 papers on this subject2023: 2,800 of every 10,000 papers on this subject2024: 1,955 of every 10,000 papers on this subject2025: 1,640 of every 10,000 papers on this subject▼ -19% share2022→2025 share of research on this subject
Cancer research · Cancer · Senescence · Tumor microenvironment
“Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?”
Caenorhabditis Elegans / Longevity — Opportunities
Opportunities · theme 06
Caenorhabditis Elegans / Longevity
630 papers · 10.5% of this block
2022: 55 of every 10,000 papers on this subject2023: 50 of every 10,000 papers on this subject2024: 54 of every 10,000 papers on this subject2025: 59 of every 10,000 papers on this subject2022: 55 of every 10,000 papers on this subject2023: 50 of every 10,000 papers on this subject2024: 54 of every 10,000 papers on this subject2025: 59 of every 10,000 papers on this subject▲ +6% share2022→2025 share of research on this subject
Caenorhabditis elegans · Longevity · Drosophila melanogaster · Drosophila
“Lysosomal signaling molecules regulate longevity in <i>Caenorhabditis elegans</i>”
Longevity / Fecundity — Opportunities
Opportunities · theme 07
Longevity / Fecundity
555 papers · 9.2% of this block
2022: 75 of every 10,000 papers on this subject2023: 64 of every 10,000 papers on this subject2024: 59 of every 10,000 papers on this subject2025: 57 of every 10,000 papers on this subject2022: 75 of every 10,000 papers on this subject2023: 64 of every 10,000 papers on this subject2024: 59 of every 10,000 papers on this subject2025: 57 of every 10,000 papers on this subject▼ -24% share2022→2025 share of research on this subject
Longevity · Fecundity · Honey bee · Larva
“More on seed longevity phenotyping”

Which of these themes are growing fastest

Tracks how the share of research themes has shifted worldwide between 2022 and 2025.

Problems
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Immune System / Disease▲+1%
Reproduction / Fecundity▼-4%
Gerontology / Longevity▼-24%
Demography / Life Expectancy▼-25%
Longevity / Longevity Risk▼-30%
Longevity / Internal Medicine▼-38%
Senescence / Cellular Senescence▼-40%
Cautions
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Honey Bee / Pesticide▼-7%
Longevity / Gerontology▼-25%
Senescence / Cell Biology▼-31%
Senescence / Mesenchymal Stem Cell▼-37%
Longevity / Caenorhabditis Elegans▼-37%
Internal Medicine / Calorie Restriction▼-38%
Longevity / Fecundity▼-43%
Opportunities
how much more (or less) of the world’s research on this subject each theme took up, 2022→2025
gaining sharelosing share
Caenorhabditis Elegans / Longevity▲+6%
Cancer Research / Cancer▼-19%
Longevity / Fecundity▼-24%
Longevity / Gerontology▼-25%
Senescence / Autophagy▼-33%
Senescence / Cell Biology▼-36%
Senescence / Cell Biology▼-40%
Prism

Go deeper on Age Tech and Longevity research and innovation

Research themes, patent activity and the companies commercialising them, in one place.

Keep going

Track Age Tech and Longevity in the United States beyond this page

Radar finds and filters the companies. Prism watches what is being said about them.

About this data: built from Fliar's company, founder, funding, hiring, jobs and research trackers, covering the United States. Counts are of companies we track, not of every company that exists. Updated September 2026.
Coming soon